Centene Corporation ($CNC) Stock Forecast: Up 5.2% Today

What is Centene Corporation?

Centene Corporation (CNC) is a managed healthcare company that operates government-sponsored healthcare programs in the United States. The company has recently reported strong Q1 earnings and received positive attention from analysts, leading to a bullish market movement.

Why is Centene Corporation going up?

CNC stock is up 5.2% on Jun 8, 2026 19:21

• Centene's price target was raised to $60 by JP Morgan, indicating growing confidence in the company's performance and potential for future growth.
• Q1 earnings exceeded expectations, demonstrating the company's ability to enhance margins and implement strategic initiatives effectively.
• Inclusion in Bank of America's "US 1 List" and receiving higher price targets from analysts like Barclays reflect a favorable sentiment towards Centene's earnings outlook and market position.
• Strong operational performance in Medicaid and Medicare segments, along with being recognized as one of the World's Most Admired Companies, drive Centene's bullish market momentum, despite potential challenges in revenue expansion.

CNC Price Chart

CNC Technical Analysis

CNC News

CNC Maintained by JP Morgan -- Price Target Raised to $60

JP Morgan analyst John Stansel maintained a "Neutral" rating for Centene (CNC) and raised its price target from $52.00 to $60.00. GuruFocus indicates that Centene is currently undervalued by approximately 25.2% with a GF Value™ of $83.82 against a current price of $62.67. Despite a strong GF Score™ of 73/100, its growth rank is low at 2/10, suggesting potential challenges in expanding revenue streams, though profitability and valuation are above average.

https://www.gurufocus.com/news/8905614/cnc-maintained-by-jp-morgan-price-target-raised-to-60

Centene Corp stock (US15135B1017): Q1 earnings beat and fresh analyst interest

Centene Corp (CNC) reported a strong Q1 2026 earnings beat, with adjusted diluted EPS of $3.37, significantly exceeding internal expectations. This performance, coupled with renewed attention from Wall Street banks like Barclays and Bank of America, highlights the health insurer's progress in margin improvement and strategic execution. The article emphasizes that while the positive momentum is notable, investors should continue to monitor industry trends and policy risks given Centene's exposure to government-sponsored healthcare programs.

https://www.ad-hoc-news.de/boerse/news/ueberblick/centene-corp-stock-us15135b1017-q1-earnings-beat-and-fresh-analyst/69500893

Is Centene (CNC) Most Undervalued Stocks to Buy and Hold for 2 Years?

Centene Corporation (NYSE: CNC) is highlighted as one of the most undervalued stocks to buy and hold for two years, following strong Q1 2026 financial results that exceeded expectations and led to increased full-year guidance. The company reported adjusted diluted EPS of $3.37, reduced debt by $1.0 billion, and showed robust operational performance across its Medicaid and Medicare segments. Centene also received recognition as one of the World's Most Admired Companies for the eighth consecutive year, showcasing its commitment to operational discipline and community engagement.

https://www.insidermonkey.com/blog/is-centene-cnc-most-undervalued-stocks-to-buy-and-hold-for-2-years-1777113/

Centene (CNC) Earns A Spot On Bank Of America’s Highest-Conviction List

Centene Corporation (NYSE: CNC) has been added to Bank of America's prestigious "US 1 List," signifying high conviction for investment. This comes as Barclays also increased its price target for Centene to $75 from $63, maintaining an Overweight rating. The healthcare company, with 72 hedge fund holders as of Q1 2026, is seen to benefit from favorable industry dynamics and government-sponsored healthcare programs despite rising cost pressures for providers.

https://www.insidermonkey.com/blog/centene-cnc-earns-a-spot-on-bank-of-americas-highest-conviction-list-1776342/

Centene (CNC) Earns A Spot On Bank Of America’s Highest-Conviction List

Centene Corporation (NYSE: CNC) has been added to Bank of America's "US 1 List," signifying it as a high-conviction investment idea with attractive risk-reward potential. This move, coupled with Barclays increasing its price target on Centene to $75 from $63, highlights growing institutional confidence in the company's earnings outlook. Centene, a U.S. managed healthcare company, is well-positioned to benefit from favorable industry dynamics and long-term demand growth due to its strong exposure to government-sponsored healthcare programs amidst rising cost pressures for providers.

https://finance.yahoo.com/markets/stocks/articles/centene-cnc-earns-spot-bank-224346095.html

Trending Today

IPG Photonics Corporation ($IPGP) Stock Forecast: Down 5.0% Today

International Paper Company ($IP) Stock Forecast: Down 5.4% Today

Hewlett Packard Enterprise Company ($HPE) Stock Forecast: Down 5.4% Today

Sonos Inc. ($SONO) Stock Forecast: Down 5.1% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Down 5.5% Today

Teradyne, Inc. ($TER) Stock Forecast: Down 5.1% Today

Elevance Health Inc. ($ELV) Stock Forecast: Down 5.1% Today

QUALCOMM Incorporated ($QCOM) Stock Forecast: Down 5.4% Today

Quanta Services Inc. ($PWR) Stock Forecast: Down 5.2% Today

Mosaic Company (The) ($MOS) Stock Forecast: Down 5.1% Today

Centene Corporation Price History

04.05.2026 - CNC Stock was up 5.6%

• CNC stock displayed strong bullish momentum despite a lackluster performance the previous day.
• Investor confidence in Centene's strategic focus on Medicaid and government programs could be influencing the positive trend.
• Market sentiment may be optimistic about Centene's growth prospects, given favorable industry trends mentioned in the Zacks Industry Outlook.
• Despite recent declines and comparisons to peers, CNC's distinctive risk profile and market positioning could be fostering investor optimism about its future performance.

04.05.2026 - CNC Stock was up 5.6%

• Centene Corporation, a healthcare giant, has recently seen a significant uptrend in the market.
• The stock price of Centene rose notably today, possibly due to the overall positive performance of healthcare plans.
• Analysts adjusted their price target for CNC from "Equal-Weight" at Morgan Stanley, showing increased confidence in the company.
• Despite initial concerns stemming from a lawsuit against JAL Equity for alleged fund diversion, the prevailing optimistic industry outlook has overshadowed this issue.
• CNC's undervaluation relative to its GF Value™ and strong profitability measures may be additional factors driving the current bullish trend.

04.05.2026 - CNC Stock was up 5.3%

• CNC's stock price surged as part of a sector-wide rally in healthcare plans, with other companies experiencing significant gains.
• An investment firm maintained an "Equal-Weight" rating on CNC but raised its price target, indicating confidence in the company's valuation and profitability.
• The bullish movement in CNC could be attributed to the overall positive sentiment in the healthcare sector, driven by factors such as institutional investors rotating into managed care names and favorable industry trends.
• The lack of a specific company-driven catalyst suggests that CNC's rise is more reflective of growing confidence in the sector as a whole rather than internal developments within Centene itself.

08.05.2026 - CNC Stock was up 5.2%

• Centene's price target was raised to $60 by JP Morgan, indicating growing confidence in the company's performance and potential for future growth.
• Q1 earnings exceeded expectations, demonstrating the company's ability to enhance margins and implement strategic initiatives effectively.
• Inclusion in Bank of America's "US 1 List" and receiving higher price targets from analysts like Barclays reflect a favorable sentiment towards Centene's earnings outlook and market position.
• Strong operational performance in Medicaid and Medicare segments, along with being recognized as one of the World's Most Admired Companies, drive Centene's bullish market momentum, despite potential challenges in revenue expansion.

08.05.2026 - CNC Stock was up 4.4%

• Centene's strong Q1 earnings beat and increased full-year guidance have captured investor interest and confidence in the company's future.
• Inclusion in Bank of America's prestigious "US 1 List" and a higher price target from Barclays signify institutional faith in Centene's financial outlook and market position.
• Cigna's exit from Florida's Obamacare market, potentially enhancing Centene's market share in government-sponsored healthcare programs, highlights the company's strong presence in the sector.
• Centene's emphasis on operational efficiency, community involvement, and dedication to government-sponsored healthcare programs positions it well to navigate industry shifts and policy uncertainties.

29.03.2026 - CNC Stock was up 16.7%

• Centene's Q1 2026 adjusted diluted EPS of $3.37 surpassed estimates, resulting in an increased full-year EPS forecast, indicating robust operational enhancements and effective cost management.
• Analyst upgrades from Cantor Fitzgerald and Mizuho, coupled with favorable investor sentiment, boosted the stock's performance, showcasing belief in Centene's margin growth and overall execution.
• Emphasis on program integrity, risk adjustment oversight, and balance sheet efficiency demonstrated Centene's dedication to sustainable expansion, meeting market expectations and driving the positive momentum in the stock.

29.03.2026 - CNC Stock was up 10.6%

• CNC's upward momentum can be credited to its strong Q1 2026 financial results, surpassing expectations with higher adjusted diluted EPS and an upgraded full-year EPS forecast.
• The market reacted favorably to CNC's effective management of medical expenses and trends in various segments, reflecting operational enhancements and a commitment to program integrity.
• Investor mood was likely influenced by prominent investor David Einhorn's optimistic view on Centene Corporation, emphasizing its robust performance and improved Health Benefits Ratio.
• CNC's surge may have also been impacted by the positive overall market sentiment towards healthcare stocks, as illustrated by the strong performance of other healthcare companies like LifeStance Health Group.

29.03.2026 - CNC Stock was up 10.4%

• Centene Corporation (CNC) witnessed a significant bullish movement today.
• The uptrend is believed to be a result of the company's impressive Q1 2026 earnings, surpassing expectations and leading to an upward revision of its full-year EPS forecast.
• Positive reactions from analysts and commendations from firms like Cantor Fitzgerald, who point out a clearer route to margin enhancement, also bolstered the stock's climb.
• Investor sentiment appears buoyant due to Centene's effective management of medical expenses, enhancements in operations, and robust performance across its primary sectors.

28.03.2026 - CNC Stock was up 15.3%

• CNC stock surged over 12% today, reflecting a strong bullish movement.
• The favorable regulatory developments for Centene, such as the approval of 2027 Medicare Advantage and Part D policies with a 2.48% payment rate increase, contributed to the positive market movement. This boosted revenue visibility and reduced regulatory risk.
• Centene increased its profit outlook for 2026 by implementing tighter control over medical expenses and surpassing analyst expectations in Q1 2026 results. This led to higher investor confidence in the company's strategic initiatives and financial outlook.
• Investors are optimistic about Centene's cost management efficiency and growth prospects in the healthcare sector, evident in the market's positive reaction.

28.03.2026 - CNC Stock was up 12.8%

• CNC experienced a strong bullish movement following its Q1 2026 earnings report, which exceeded expectations across the board.
• The company's adjusted EPS of $3.37 and revenue of $49.94 billion surpassed analyst forecasts, leading to a positive investor sentiment and a stock price increase of over 6% in pre-market trading.
• CNC's strong performance was driven by Medicaid expansion in Texas and improved operational efficiency across its segments, reflecting the company's strategic initiatives and financial outlook.
• Analysts responded to the earnings beat by raising price targets, indicating confidence in Centene's continued growth trajectory and market position in the healthcare sector.

13.04.2026 - CNC Stock was up 5.4%

• CNC shares rose by 6.0% to $59.31, indicating a bullish market trend.
• Despite being viewed as substantially undervalued with a GF Value™ of $84.31, there have not been recent insider transactions, suggesting a neutral stance from insiders.
• TD Cowen emphasized positive long-term prospects for CNC, raising the price target to $48 after strong Q1 2026 results that surpassed expectations and showed substantial revenue growth.
• Greenlight's David Einhorn recommended CNC as a long idea at the Sohn Investment conference, potentially contributing to the bullish movement and enhancing investor confidence in the stock.

12.04.2026 - CNC Stock was up 5.4%

• CNC stock showed positive movement today.
• The partnership with the Seattle Seahawks for the Strong Youth Strong Communities youth mental health summit likely enhanced positive perceptions around Centene's brand and values.
• The robust Q1 2026 earnings report, with GAAP EPS of $3.11, highlighted the company's financial stability and potential for growth.
• Centene's reputation as one of the top healthcare stocks for long-term investment further bolstered investor confidence, particularly due to its focus on innovative healthcare solutions and strong position in the managed care sector.